Inceptiv™ neurostimulator Spinal cord stimulation for pain management

Inceptiv™ is a spinal cord stimulator with closed-loop technology for chronic pain relief. 

Get the brochure


  Follow us

Transforming SCS therapy through sensing​

Discover why Inceptiv is the most advanced SCS system with automatic closed-loop sensing technology, the best full body 1.5T and 3T MRI access†† and the smallest and thinnest SCS device. 

Need for consistent therapy​

Fixed-output systems do not account for shifts in lead-to-spinal cord distance, which may result in inconsistent therapy dose.1

Patients need to make adjustments to deliver optimal therapy, regardless of waveform. Inconsistent dosing can lead to variable therapy experience.

Fixed imput

Variability in electrode distance to spinal cord due to activities and position

Inceptiv™ SCS system senses† and responds.

Medtronic closed-loop senses neural response and automatically adjusts stimulation to maintain consistent therapy during all patient activities.

Inceptiv™ device
50x Per Second
3K Per Minute
1B Per Year

Superior back pain relief,‡,3 personalized

The Inceptiv™ system now adjusts DTM™ SCS therapy, moment-to-moment

back pain responder rate reported at 12 months (≥50% improvement).‡,3

were profound back pain responders (≥80% pain relief).‡,3

† Sensing signals may not be measurable in all cases.
‡ DTM™ SCS superior outcomes demonstrated using open-loop SCS therapy.
 ††Under specific conditions. Refer to product labeling for full list of conditions.

Your Inceptiv™ SCS patients can now enjoy greater freedom.

More consistent therapy, more time for life

9 out of 10 patients preferred using the Inceptiv™ closed-loop algorithm over fixed-output stimulation.1

does not depend on adjustments from the patient to maintain stimulation

instantly adjusts therapy delivery in real time

provides consistent therapy while patients perform a full range of daily activities

Best full-body 1.5T and 3T MRI access††

With impedance independence


Full body MRI



of patients are expected to need an
MRI within 10 years post implant4



access to MRI scanners5
(1.5T and 3T versus 68% 1.5T only)††



access compared to 57% for Abbott, Boston Scientific, and Nevro patients due to high electrode impedance at five years††,§,6


Inceptiv™ offers the most access to life-changing diagnostic imaging††

Know the Medtronic difference.

  Medtronic††,7 Biotronik8 Boston
Saluda11 Nevro12,13 Abbott14
Able to scan high impedance or fracture lead
Able to scan fully discharged device
3T full-body
1.5T full body normal operating mode with every lead in the portfolio
Able to scan patient in prone position e.g., breast MR

Proceed with full-body MRI scan      Does not meet criteria

Smallest and thinnest

Designed for comfort


Talk Icon

Talk to
a representative.

If you have additional questions, sign up to speak with a Medtronic representative.

Head Icon

Learn more
about SCS.

Visit the Medtronic SCS page to get more product and clinical information.

Download Icon

Continue reading about Inceptiv™.

Download the brochure for more information.

 †† Under specific conditions. Refer to product labeling for full list of conditions
§ Assuming all other MRI conditions have been met.


ECHO MAC Final Clinical Study Report RAD V 1.0 July 18, 2021.


Vallejo R, Chakravarthy K, Will A, Trutnau K, Dinsmoor D. A new direction for closed-loop spinal cord stimulation: combining contemporary therapy paradigms with evoked compound action potential sensing. J Pain Res. 2021;14:3909-3918. doi: 10.2147/JPR. S344568.


Fishman M, Cordner H, Justiz R, et al. Twelve-month results from multicenter, open-label, randomized controlled clinical trial comparing differential target multiplexed spinal cord stimulation and traditional spinal cord stimulation in subjects with chronic intractable back pain and leg pain. Pain Pract. 2021 Nov;21(8):912–923.


Desai MJ, Hargens LM, Breitenfeldt MD, et al. The rate of magnetic resonance imaging patients with spinal cord stimulation. Spine (Phila Pa 1976). 2015;40(9):E531–537.


Diagnostic Imaging Equipment Servicing. Market Insights. United States: Clarivate; 2022. Report No. 47031054.


Mullins CF, Harris S, Pang D. A retrospective review of elevated lead impedances in impedance-dependent magnetic resonance-conditional spinal cord stimulation devices. Pain Pract. 2023;00:1-8.


MRI Guidelines for Medtronic neurostimulation systems for chronic pain, February 2021.


Prospera spinal cord stimulation system ProMRI MRI guidelines technical manual. 461825, revision D (2023-04-03).


ImageReady™ MRI full body guidelines for precision™ montage™ MRI spinal cord stimulator system. 2017 Boston Scientific Corporation. 91075353-04 rev A 2017-09.


Boston ImageReady™ MRI full body guidelines for WaveWriter Alpha™ and WaveWriter Alpha™ Prime Systems 92395569-01.


Saluda Evoke® SCS system MRI guidelines for US. D102263 rev 5.00. 25 Sep 2023.


1.5 Tesla and 3 Tesla magnetic resonance imaging (MRI) guide linesfor the SENZA® neuromodulation systems. 11096 rev M.


1.5 Tesla and 3 Tesla magnetic resonance imaging (MRI) guidelines for Senza® HFX iQ™ system. 10001162 rev B.


MRI procedure information Abbott Medical MR conditional spinal cord stimulation systems Dorsal Root Ganglion neurostimulation systems | Abbott. ARTEN600132616 A. 2022-12.


mail icon

Talk to a Medtronic rep

Complete this form to receive additional information from a Medtronic representative about how spinal cord stimulation is working to address chronic pain.